Literature DB >> 9844628

VEGF gene delivery to muscle: potential role for vasculogenesis in adults.

M L Springer1, A S Chen, P E Kraft, M Bednarski, H M Blau.   

Abstract

Constitutive expression of VEGF after implantation of genetically engineered myoblasts into non-ischemic muscle led to an increase in vascular structures. Previously, effects of VEGF delivery to adult muscle have only been reported in ischemic tissues. The resulting vascular structures were reminiscent of those formed during embryonic vasculogenesis, rather than angiogenesis, sprouting from preexisting vessels. Initially, VEGF caused an accumulation of endothelial cells and macrophages, followed by networks of vascular channels and hemangiomas with locally high serum VEGF levels. No effects were evident in adjacent tissue or contralateral legs, where low serum VEGF was detected. These data suggest that the induction by VEGF of angiogenesis or vasculogenesis may be dose-dependent. Furthermore, VEGF expression must be carefully modulated, as overexpression is deleterious.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9844628     DOI: 10.1016/s1097-2765(00)80154-9

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  81 in total

Review 1.  Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.

Authors:  J M Isner; T Asahara
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 2.  Vascular growth factors in cerebral ischemia.

Authors:  S D Croll; S J Wiegand
Journal:  Mol Neurobiol       Date:  2001 Apr-Jun       Impact factor: 5.590

3.  Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart.

Authors:  H Su; R Lu; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

4.  Rac regulates endothelial morphogenesis and capillary assembly.

Authors:  John O Connolly; Nandi Simpson; Lindsay Hewlett; Alan Hall
Journal:  Mol Biol Cell       Date:  2002-07       Impact factor: 4.138

Review 5.  Myoblast-mediated gene transfer for therapeutic angiogenesis and arteriogenesis.

Authors:  Georges von Degenfeld; Andrea Banfi; Matthew L Springer; Helen M Blau
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

6.  Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.

Authors:  Clare R Ozawa; Andrea Banfi; Nicole L Glazer; Gavin Thurston; Matthew L Springer; Peggy E Kraft; Donald M McDonald; Helen M Blau
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

7.  Angiomyeloproliferative lesions following autologous stem cell therapy.

Authors:  Duangpen Thirabanjasak; Kavirach Tantiwongse; Paul Scott Thorner
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

8.  Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.

Authors:  Hairong Peng; Vonda Wright; Arvydas Usas; Brian Gearhart; Hsain-Chung Shen; James Cummins; Johnny Huard
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 9.  Complementary actions of VEGF and angiopoietin-1 on blood vessel growth and leakage.

Authors:  Gavin Thurston
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

10.  Positron-emission tomography reporter gene expression imaging in rat myocardium.

Authors:  Masayuki Inubushi; Joseph C Wu; Sanjiv S Gambhir; Gobalakrishnan Sundaresan; Nagichettiar Satyamurthy; Mohammad Namavari; Simon Yee; Jorge R Barrio; David Stout; Arion F Chatziioannou; Lily Wu; Heinrich R Schelbert
Journal:  Circulation       Date:  2003-01-21       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.